Name: Francisco Quintana PhD
Affiliation: Associate Scientist, Brigham and Women’s Hospital
Professor of Neurology, Harvard Medical School
Brigham and Women’s Hospital
Department of Neurology
Dr. Quintana, a graduate of the University of Buenos Aires (1999, Argentina), obtained his PhD in Immunology at the Weizmann Institute of Science (2004, Israel). He received postdoctoral training at the Weizmann Institute of Science and at Brigham and Women’s Hospital, Harvard Medical School. In 2009, Dr. Quintana joined the faculty of Harvard Medical School, and in 2015, Dr. Quintana become an Associate Member of the Broad Institute of Harvard and MIT. Dr. Quintana is the recipient of the Lady Anne Chain Prize for Academic Excellence and Scientific Achievements (Israel), the Junior Investigator Award from the National Multiple Sclerosis Society, the Pathway to Independence Award of the National Institute of Allergy and Infectious Diseases, the Award for Outstanding Research Achievement form Nature Biotechnology and the Tecan Award for Innovation, the Harry Weaver Award from the National Multiple Sclerosis Society and the Harvard School of Medicine Mentor Award.
Dr. Quintana’s research investigates signaling pathways that control the immune response, with the ultimate goal of identifying novel therapeutic targets and biomarkers for immune-mediated disorders. Dr. Quintana has published over 140 peer reviewed articles and book chapters. Dr. Quintana’s research is funded through grants from the National Institutes of Health, the National Multiple Sclerosis Society, Juvenile Diabetes Research Foundation, the American Cancer Society and other foundations and industry. Dr. Quintana is a permanent member of study sections at the National Institutes of Health, the National Multiple Sclerosis Society, the Type 1 Juvenile Diabetes Research Foundation and the Wellcome Trust Peer Review College (UK), and he is also an ad hoc reviewer for the Israel Science Foundation, the US-Israel Binational Science Foundation and the Ministry of Science of Israel.